Hikma's Advair Generic Gets Further Delayed Post author:Sam Post published:March 11, 2018 Post category:BioPharma Hikma Pharmaceuticals generic version of Advair has hit a stumbling block with the FDA. Source: BioSpace You Might Also Like The Biotech Job Title You've Probably Never Heard Of April 26, 2017 DelMar Pharma Announces Fiscal Year 2017 Financial Results September 28, 2017 4 Drug Stocks With Major FDA Decisions Coming This Month April 2, 2017
